Skip to content
TrialMatch
Sign up
Recruiting

COLORECTUM+ Digital System for Postoperative Quality Improvement in Colorectal Cancer

Create a profile to match View the full record on ClinicalTrials.gov

About this study

This is a single-center, prospective, interventional study. A total of 236 colorectal cancer patients who underwent surgery will be enrolled and followed for 52 weeks. The digital healthcare quality management system, based on the COLORECTUM+ model, will be used for post-treatment quality evaluation and continuous improvement. Patients will be managed using an Internet+ post-treatment healthcare management platform. The platform integrates AI technology for real-time symptom analysis and alerts. Patients will report symptoms and health data through the platform, which will generate alerts based on symptom severity to guide appropriate interventions. Follow-up assessments will include patient adherence, satisfaction, quality of life, and healthcare utilization. The study expects to demonstrate that the digital healthcare quality management system improves follow-up rates, enhances patient adherence, reduces unplanned hospital visits, and increases overall patient satisfaction. The findings aim to provide evidence for the implementation of digital management systems in colorectal cancer post-treatment care, potentially leading to improved long-term outcomes for patients.

Condition
Colorectal Carcinoma
Tested
Mobile application follow-up
Sponsor
RenJi Hospital

Who can join

Age
18 years and older
Sex
All sexes
Healthy volunteers
Not accepted

Inclusion 6

  • Minimum age: 18 years
  • Study condition: Colorectal Carcinoma
  • Over 18 years old.
  • Pathologically confirmed colorectal cancer patients.
  • Underwent surgery at the Colorectal Cancer Diagnosis and Treatment Center, Gastrointestinal Surgery, Renji Hospital, Shanghai Jiao Tong University School of Medicine.
  • Signed informed consent form.

Exclusion 4

  • Unable to access electronic devices that can connect to the internet or mobile communications.
  • Uncontrolled psychiatric illness.
  • The ECOG score is greater than or equal to 3.
  • Deemed unsuitable for participation by the investigator.

Where

1 site, 1 recruiting

Shanghai Jiao Tong University School of Medicine, Renji Hospital

Shanghai, China

Recruiting

Contact

Potential match only. Final eligibility is determined by the study team.